What is adenomyosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Adenomyosis

Adenomyosis is a benign uterine disorder where endometrial glands and stromal tissue are pathologically present within the myometrium (uterine muscle layer), causing the myometrium to undergo hyperplasia and hypertrophy. 1

Pathological Definition

  • Adenomyosis represents endometrial-like tissue located abnormally within the myometrium, characterized by endometrial epithelial cells and stromal fibroblasts embedded in the muscle wall where they trigger surrounding smooth muscle cell proliferation and enlargement. 2

  • The condition is distinct from endometriosis, though it is sometimes classified as a specific subtype in certain deep endometriosis classification systems; however, adenomyosis remains a separate clinical entity. 3

  • The gold standard histopathological definition remains controversial, with poor inter-observer reproducibility in limited disease, leading to significant variations in reported disease prevalence. 1

Clinical Characteristics

  • Adenomyosis is an estrogen-dependent disease that presents with a wide spectrum of manifestations, from completely asymptomatic to severe symptoms including dysmenorrhea (painful menstruation), heavy menstrual bleeding (HMB), chronic pelvic pain, dyspareunia, and infertility. 4, 5

  • The disease causes uterine enlargement and is associated with inflammation, fibrosis, neurogenesis, and angiogenesis within both endometrial and myometrial components. 2

  • Adenomyosis frequently coexists with other gynecological conditions, particularly endometriosis and uterine fibroids, which complicates the diagnostic process. 1

Pathophysiological Mechanisms

The development of adenomyosis likely involves multiple pathogenic pathways: 2

  • Microtrauma at the endometrial-myometrial interface with enhanced invasion of endometrium into myometrium
  • Metaplasia of stem cells within the myometrium
  • Inside-to-outside invasion from the endometrial side into the uterine wall
  • Outside-to-inside invasion from the serosal side (via retrograde menstrual effluent infiltration)
  • Epithelial-mesenchymal transition with tissue remodeling
  • Aberrant local steroid hormone signaling with progesterone resistance

Diagnostic Approaches

  • Transvaginal ultrasound can diagnose adenomyosis with sensitivity of 82.5% and specificity of 84.6%. 3

  • MRI provides superior visualization of the endometrium even when adenomyosis is present, which may be obscured on ultrasound. 3

  • An integrated diagnostic approach is recommended, combining risk factor assessment, clinical symptoms, physical examination findings, and imaging (2D/3D ultrasound or MRI) to identify both diffuse and focal phenotypes of adenomyosis. 1

Disease Phenotypes

  • Diffuse adenomyosis shows widespread involvement of the myometrium and is straightforward to diagnose histologically. 1

  • Focal adenomyosis (adenomyoma) represents more limited disease with challenging histological diagnosis and poor reproducibility. 1

References

Research

Adenomyosis: Mechanisms and Pathogenesis.

Seminars in reproductive medicine, 2020

Guideline

Adénomyose et Endométriose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Conservative surgical treatment for adenomyosis: New options for looking beyond uterus removal.

Best practice & research. Clinical obstetrics & gynaecology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.